Work / Xelios
Xelios: lab automation for advanced cell workflows.
Xelios is a company in formation. It aims to make advanced cell-lab work easier to repeat and to control, using robotics, AI, image-based quality checks and structured run data. It starts with research use only: work in research labs, not in clinics or diagnosis.
Where it stands
Three pieces of work are under way. Together they will show whether the evidence supports forming the company.
Xelios is not offered as a clinical, diagnostic or commercial product, and it is not generally available.
As of November 2026.
- Company formation
- Whether the evidence supports a new company.In progress
- Conversations with labs
- Whether labs see this problem and would take part in a pilot.Under way
- Research-use pilot
- What the first pilot covers and how its results would be judged.Being defined
What is being tested now
First workflow
Research-use automation for advanced cell-lab work where reproducibility and workflow control matter.
Technical assumptions
Image-based quality checks, structured run data and robotic workflow control are under test.
Commercial proof
Buyer conversations and pilot scoping test whether this workflow can support a company.
Want to know more about Xelios?
We share more detail in private conversations where there is a clear reason to.